181 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
173
S-063 (d)
Symposium (German)
08:15–09:45
|
Hall London 1
TOPIC 18:
Pharmacotherapy
Unterstützung einer rationalen und rationellen
Arzneimitteltherapie
›
AGATE – Arbeitsgemeinschaft Arzneimitteltherapie
bei psychiatrischen Erkrankungen e.V.
Chairs:
Ekkehard Haen, Germany
Irene Berti, Italy
001
Verordnung von Antipsychotika 2009–2016
Benedikt Stegmann, Germany
002
Leukopenie – Thrombopenie – Eosinophilie:
UAW an den blutbildenden Organen
Armin Gerbitz, Germany
003
Der klinisch-pharmakologische Befund zu einer
Wirkstoffkonzentration
Ekkehard Haen, Germany
004
Wirkstoffkonzentrationsbestimmungen zur
Therapieleitung unter Depot-Antipsychotika (LAI)
Andreas Conca, Italy
Daria Piacentino, Fabio Carpi
S-064 (d)
Symposium (German)
08:15–09:45
|
Room Lindau 3
TOPIC 20:
Prevention and health promotion
Vom Behandelten zum Handelnden – Erfah-
rungsexperten (people with lived experience) in
innovativen Settings
Chairs:
Martin Schultz, Germany
Uwe Wegener, Germany
001
Peer in der Praxis / Peers in Praxen
Uwe Wegener, Germany
002
Peers im betrieblichen Setting (Teil 1)
Martin Schultz, Germany
003
Peers im betrieblichen Setting (Teil 2)
Manfred Schneider, Germany
004
Peers in Schulen / Hochschule (Teil 1)
Imke Schrader, Germany
005
Peers in Schulen / Hochschule (Teil 2)
Katharina Pretscher, Germany
WS-21
Workshop
08:15–09:45
|
Room M8
TOPIC 19:
Stimulation methods and interdisciplinary
interventions
Basic concepts of rTMS, gauging effectiveness
of rTMS effects plus possible neuroanatomical
correlates and hands-on training
Chairs:
Adel Marei, Egypt
Jakob Kaminski, Germany
Speaker:
Hussien Elkholy, Egypt
WS-22
Workshop
08:15–09:45
|
Room M6
TOPIC 25:
Training and continuing education
Teaching psychopharmacology in low and middle in-
come countries (LAMIC): a WPA/AACP collaboration
Chairs:
Driss Moussaoui, Morocco
Sidney Zisook, USA
OS-38
Oral Presentation Session
08:15–09:45
|
Room R12
TOPIC 18:
Pharmacotherapy
Pharmacotherapy
Chairs:
Gerhard Gründer, Germany
Alex Hofer, Austria
001
Risks associated with first-trimester pregnancy
exposure to duloxetine
Niels Bergemann, Germany
Wolfgang E. Paulus
002
An investigation of cardiovascular risks in a
group of children and adolescents who use atypical
antipsychotics
Gül Dikec, Turkey
Leyla Baysan Arabaci, Gulcin Uzunoglu, Selin Demet
Mizrak
003
Arterial hyper- and hypotension associated
with psychiatric medications: a risk assessment
based on the German summaries of product
characteristics (SmPCs)
Roland Freudenmann, Germany
Bartosz Zurowski, Carlos Schönfeldt-Lecuona, Ludwig
Maier, Christian Lange-Asschenfeldt, Maximilian Gahr
004
Bacloville: a clinical efficacy study of high dose
baclofen in reducing alcohol consumption in high
risk drinkers
Philippe Jaury, France
Stéphanie Sidorkiewicz